PCI Biotech Holding ASA (PCIB) — Working Capital to Net Assets Ratio
PCI Biotech Holding ASA (PCIB) has a Working Capital to Net Assets ratio of 93.2% as of June 2025. Working capital of Nkr11.66 Million (current assets of Nkr17.67 Million minus current liabilities of Nkr6.01 Million) is measured against net assets of Nkr12.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of PCI Biotech Holding ASA to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PCI Biotech Holding ASA Working Capital to Net Assets (2008–2024)
This chart shows how PCI Biotech Holding ASA's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 93.2%, reflecting working capital of Nkr11.66 Million against net assets of Nkr12.52 Million NOK. For the complete balance sheet picture, see PCI Biotech Holding ASA assets under control.
Annual Working Capital to Net Assets for PCI Biotech Holding ASA (2008–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for PCI Biotech Holding ASA from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PCIB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.7% | Nkr23.14 Million | Nkr23.45 Million | Nkr30.91 Million | Nkr7.76 Million | ▼ -0.6 pp |
| 2023 | 99.3% | Nkr38.78 Million | Nkr39.04 Million | Nkr43.75 Million | Nkr4.97 Million | ▲ +0.0 pp |
| 2022 | 99.3% | Nkr57.01 Million | Nkr57.40 Million | Nkr62.76 Million | Nkr5.75 Million | ▲ +4.9 pp |
| 2021 | 94.4% | Nkr107.41 Million | Nkr113.79 Million | Nkr128.32 Million | Nkr20.91 Million | ▼ -1.4 pp |
| 2020 | 95.8% | Nkr181.28 Million | Nkr189.24 Million | Nkr201.13 Million | Nkr19.85 Million | ▼ -2.8 pp |
| 2019 | 98.5% | Nkr251.12 Million | Nkr254.83 Million | Nkr275.75 Million | Nkr24.63 Million | ▼ -1.5 pp |
| 2018 | 100.0% | Nkr340.04 Million | Nkr339.95 Million | Nkr357.04 Million | Nkr17.00 Million | ▼ -4.7 pp |
| 2017 | 104.7% | Nkr43.83 Million | Nkr41.84 Million | Nkr58.41 Million | Nkr14.59 Million | ▲ +4.8 pp |
| 2016 | 100.0% | Nkr13.08 Million | Nkr13.09 Million | Nkr22.39 Million | Nkr9.31 Million | ▼ 0.0 pp |
| 2015 | 100.0% | Nkr44.27 Million | Nkr44.28 Million | Nkr56.39 Million | Nkr12.12 Million | ▲ +0.1 pp |
| 2014 | 99.8% | Nkr9.10 Million | Nkr9.11 Million | Nkr20.37 Million | Nkr11.27 Million | ▼ -0.4 pp |
| 2013 | 100.2% | Nkr43.50 Million | Nkr43.40 Million | Nkr52.72 Million | Nkr9.22 Million | ▼ -1.0 pp |
| 2012 | 101.2% | Nkr70.53 Million | Nkr69.71 Million | Nkr78.20 Million | Nkr7.67 Million | ▼ -0.7 pp |
| 2011 | 101.9% | Nkr94.32 Million | Nkr92.53 Million | Nkr100.15 Million | Nkr5.83 Million | ▼ -0.4 pp |
| 2010 | 102.3% | Nkr107.86 Million | Nkr105.42 Million | Nkr114.46 Million | Nkr6.61 Million | ▲ +2.8 pp |
| 2009 | 99.5% | Nkr34.90 Million | Nkr35.08 Million | Nkr41.35 Million | Nkr6.45 Million | ▼ -0.1 pp |
| 2008 | 99.6% | Nkr49.10 Million | Nkr49.30 Million | Nkr54.38 Million | Nkr5.28 Million | — |